Kisspeptin-10

🔹 What is Kisspeptin-10?

Class: Peptide hormone, short-chain fragment of the Kisspeptin family (RFamide-related peptides). Mechanism:

• Binds to GPR54 (KISS1R) receptors in the hypothalamus.
• Stimulates GnRH (gonadotropin-releasing hormone) release, which in turn drives LH and FSH secretion from the pituitary.
• Indirectly supports endogenous testosterone production in men and ovulation/fertility in women.

Primary focus:

• Hormonal regulation of the reproductive axis.
• Potential fertility support and enhancement of endogenous testosterone production.
• Used in research on reproductive health, puberty, and metabolic-hormonal interactions.

---

🔹 Oral Dosage: Not effective; peptide degraded in the GI tract. Only injectable or subcutaneous administration is practical.

---

🔹 Injectable / Subcutaneous Dosage (most common) Range:

• Typical dosing: 100 mcg – 200 mcgper day in research contexts, often divided into single or multiple injections.

Frequency:

• Once or twice daily subcutaneous injections are common in studies.

Rationale: Short peptide with rapid onset; subcutaneous injection ensures bioavailability and receptor engagement. Real-world example: A compounding pharmacy protocol uses a 1000 mcg/ml vial (5ml), dosed at 100 mcg subcutaneously nightly for 30 days, indicated for increasing LH (luteinizing hormone).

---

🔹 Cycle Length Common cycle length: 1–4 weeks in research protocols. Off-cycle: Breaks may be used to prevent receptor desensitization and allow hypothalamic-pituitary-gonadal axis recovery. Note: Limited human data; durations are largely extrapolated from animal studies and early clinical research.

---

🔹 Optimal Dosing Window

• Morning or early afternoon dosing aligns with natural hypothalamic activity.
• Avoid late evening dosing if stimulating LH/FSH near bedtime leads to sleep disturbances.

---

✅ Educational Integration Example (injectable / subcutaneous)

• Example protocol: 1 mg Kisspeptin-10 subcutaneous daily at 8 AM for 2 weeks.
• Can be paired with: Monitoring of LH/FSH levels to gauge pituitary response.
• Optionally combined with HCG or HMG in fertility or testosterone-support contexts.

---

🔹 Stacking Strategy (Educational / Complementary) Since Kisspeptin-10 stimulates the HPG axis, complementary strategies focus on enhancing endogenous hormone signaling and fertility support: 🔸 Male Fertility / Testosterone Support:

• HCG: Maintains intratesticular testosterone while Kisspeptin stimulates pituitary LH.
• HMG: Adds FSH support for spermatogenesis.
• Antioxidants (CoQ10, NAC, Vitamin C/E): Support sperm quality and mitochondrial function.

🔸 Female Fertility / Ovulation Support:

• HCG: Used as ovulation trigger once follicles are mature.
• FSH analogues or HMG: Assist with follicular stimulation.
• Antioxidants and mitochondrial support (CoQ10, NAD⁺ precursors): Improve oocyte quality.

Rationale: Kisspeptin-10 acts upstream in the HPG axis; stacking focuses on downstream support and optimizing reproductive hormone signaling without duplicating Kisspeptin’s direct action.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.